Loke, Yoon K, Pradhan, Shiva, Yeong, Jessica Ka-Yan and Kwok, Chun Shing (2014) Comparative coronary risks of apixaban, rivaroxaban and dabigatran:a meta-analysis and adjusted indirect comparison. British Journal of Clinical Pharmacology, 78 (4). 707–717. ISSN 0306-5251

Full text not available from this repository.

Abstract

There are concerns regarding increased risk of acute coronary syndrome with dabigatran. We aimed to assess whether alternative treatment options such as rivaroxaban or apixaban carry a similar risk as compared to dabigatran.

Item Type:	Article
Additional Information:	This article is protected by copyright. All rights reserved.
Uncontrolled Keywords:	acute coronary syndrome,apixaban,dabigatran
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Population Health (former - to 2025) Faculty of Medicine and Health Sciences > Research Centres > Mental Health and Social Care (fka Lifespan Health) Faculty of Medicine and Health Sciences > Research Centres > Public Health
Depositing User:	Pure Connector
Date Deposited:	07 Jul 2014 13:14
Last Modified:	26 Aug 2026 17:36
URI:	https://uea-test-2026.eprints-hosting.org/id/eprint/48919
DOI:	10.1111/bcp.12376

Actions (login required)

View Item